Sec. 103. Reauthorization; reporting requirements
81 words·~1 min read·
/bill/115/hr/2430/pcs/section-103·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 736B of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379h–2 ) is amended— in subsection (a)(1)— in the matter before subparagraph (A), by striking 2013 and inserting 2018 ; and in subparagraph (A), by striking Prescription Drug User Fee Amendments of 2012 and inserting ; Prescription Drug User Fee Amendments of 2017 in subsection (b), by striking 2013 and inserting 2018 ; and in subsection (d), by striking 2017 each place it appears and inserting 2022 .
Connections1 off-index
1 reference not yet in our index
- 21 USC 379h–2
Citation graph
cites case law
Sec. 103
Reauthorization; reporting requirements
Cite21 USC 379h–2
Cites 1Cited by 0 across 0 sources